Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose and outcome of care in haemophilia--how do we define cost-effectiveness?
Fischer K, Van den Berg HM, Thomas R, Kumar S, Poonnoose P, Viswabandya A, Mathews V, Kavitha ML, Bhattacharji S, Srivastava A. Fischer K, et al. Among authors: viswabandya a. Haemophilia. 2004 Oct;10 Suppl 4:216-20. doi: 10.1111/j.1365-2516.2004.01047.x. Haemophilia. 2004. PMID: 15479401
Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T-->G factor X gene mutations are responsible for congenital factor X deficiency in patients of Nepali and Indian origin.
Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, George B, Chandy M, Srivastava A. Jayandharan G, et al. Among authors: viswabandya a. J Thromb Haemost. 2005 Jul;3(7):1482-7. doi: 10.1111/j.1538-7836.2005.01339.x. Epub 2005 May 9. J Thromb Haemost. 2005. PMID: 15892863 Free article.
Surgery for hemophilia in developing countries.
Mathews V, Viswabandya A, Baidya S, George B, Nair S, Chandy M, Srivastava A. Mathews V, et al. Among authors: viswabandya a. Semin Thromb Hemost. 2005 Nov;31(5):538-43. doi: 10.1055/s-2005-922225. Semin Thromb Hemost. 2005. PMID: 16276462 Review.
Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity.
Mathews V, Desire S, George B, Lakshmi KM, Rao JG, Viswabandya A, Bajel A, Srivastava VM, Srivastava A, Chandy M. Mathews V, et al. Among authors: viswabandya a. Leukemia. 2006 May;20(5):881-3. doi: 10.1038/sj.leu.2404165. Leukemia. 2006. PMID: 16525498 Clinical Trial. No abstract available.
207 results